Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”

Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”

Saved in:

Bibliographic Details
Main Authors:	A. Ortiz Brugués, P. Sollena, M. Starace, F. Bardazzi, D. Koumaki, Z. Apalla, M. Iorizzo, C. Bost, S. Milesi, J.L. Lacaze, K. Peris, V. Sibaud
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001848
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Autoimmune bullous diseases: pathogenesis and clinical management
by: Xun Feng, et al.
Published: (2025-05-01)

Diagnosing Autoimmune Bullous Diseases—An Indian Perspective
by: Adhyatm Bhandari, et al.
Published: (2025-05-01)

Features of polymorbid pathology in patients with autoimmune bullous dermatosis
by: M. A. Ufimtseva, et al.
Published: (2021-01-01)

Bullous Skin Diseases: Classical Types of Autoimmune Diseases
by: Jan Damoiseaux
Published: (2013-01-01)

Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis
by: Lilla Mihályi, et al.
Published: (2012-01-01)

Bullous pemphigoid as a diagnostic and therapeutic challenge with a wide spectrum of dermatological symptoms
by: Przemysław Borowy, et al.
Published: (2025-01-01)

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
by: M. Strnad, et al.
Published: (2001-01-01)

Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy
by: Jonatan Kaszubski, et al.
Published: (2024-11-01)

Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
by: Razia Rahman, et al.
Published: (2025-05-01)

Regulation of hippocampal and behavioral excitability by cyclin-dependent kinase 5.
by: Ammar H Hawasli, et al.
Published: (2009-06-01)

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms
by: M. Strnad, et al.
Published: (2001-01-01)

Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases
by: Agnieszka Zebrowska, et al.
Published: (2015-01-01)

Knockout of cyclin-dependent kinases 8 and 19 leads to depletion of cyclin C and suppresses spermatogenesis and male fertility in mice
by: Alexandra V Bruter, et al.
Published: (2025-04-01)

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
by: E. V. Artamonova
Published: (2018-04-01)

Efficient activation of reconstructed rat embryos by cyclin-dependent kinase inhibitors.
by: Robin L Webb, et al.
Published: (2010-03-01)

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
by: Ilenia Pellarin, et al.
Published: (2025-01-01)

Polymorbidity in dermatological practice: symbiosis of autoimmune diseases
by: M. M. Tlish, et al.
Published: (2024-05-01)

Identification and Functional Characterisation of CRK12:CYC9, a Novel Cyclin-Dependent Kinase (CDK)-Cyclin Complex in Trypanosoma brucei.
by: Séverine Monnerat, et al.
Published: (2013-01-01)

Collagen IV immunohistochemistry and autoimmune bullous diseases: defining the location of the subepidermal bullae
by: Lula María Nieto-Benito, et al.
Published: (2025-04-01)

Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors in silico
by: Kaori Asamitsu, et al.
Published: (2025-06-01)

JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid
by: Xiaoying Lin, et al.
Published: (2025-04-01)

Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume
by: Bediz Kurt İnci, et al.
Published: (2024-09-01)

Evaluation of anticancer therapy- related dermatologic adverse events: insights from fda's faers dataset
by: S. Salah, et al.
Published: (2024-01-01)

Managing pseudophakic bullous keratopathy with a topical rho kinase inhibitor: a case series
by: Nir Erdinest, et al.
Published: (2025-05-01)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017-12-01)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

Overexpression of cyclin‐dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance
by: Han‐Jie Zhang, et al.
Published: (2021-11-01)

Pembrolizumab promotes degradation of cyclin dependent kinase 6 and suppresses ovarian cancer progression in vitro
by: Yi Wu, et al.
Published: (2025-07-01)

Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products.
by: Abhijit Debnath, et al.
Published: (2025-01-01)

Targeting the cyclin-dependent kinase family in anticancer drug discovery: From computational to experimental studies
by: Priyanka Solanki, et al.
Published: (2024-12-01)

Identification of novel cyclin-dependent kinase 4/6 inhibitors from marine natural products
by: Abhijit Debnath, et al.
Published: (2025-01-01)

Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
by: Shun-Hua Chen, et al.
Published: (2025-06-01)

Systemic and topical treatments for autoimmune bullous disease: A network meta-analysis of randomized controlled trials
by: Dan Hao, et al.
Published: (2025-03-01)

Preferential Autoimmune Response in Prostate Cancer to Cyclin B1 in a Panel of Tumor-Associated Antigens
by: Liping Dai, et al.
Published: (2014-01-01)

Prevalence and Risk of Immunostimulatory Herbal Supplement Treatment Among Autoimmune Dermatology Patients
by: Daniella F. Faden, et al.
Published: (2024-12-01)

Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
by: Petra Minarikova, et al.
Published: (2016-01-01)

Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation.
by: Ana L Alessandri, et al.
Published: (2011-01-01)

In Silico Characterization of a Cyclin Dependent Kinase -A (CDKA) and its Coding Gene in some Oryza Species
by: Ahmed Sayed Fouad, et al.
Published: (2020-07-01)

Current view of the inhibitor protein cyclin-dependent kinase р16, р27 and their role in the cell cycle
by: A. K. Aleksandrova, et al.
Published: (2016-02-01)

Cyclin dependent kinase 9 inhibitor induces transcription-replication conflicts and DNA damage accumulation in breast cancer
by: Minyoung Lee, et al.
Published: (2025-07-01)